Preparation of chorionic villus samples for metaphase chromosome analysis and chromosomal microarray analysis

Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas.
Current protocols in human genetics / editorial board, Jonathan L. Haines ... [et al.] 10/2012; Chapter 8:Unit8.3. DOI: 10.1002/0471142905.hg0803s75
Source: PubMed


Chorionic villi are composed of an outer layer of trophoblastic cells and an inner mesenchymal cell core. They can be prepared for chromosome analysis using a culture method wherein villi are disaggregated by mechanical and enzymatic methods and the resulting cell suspension is used to establish primary cultures. Mesenchymal cells of the villus core are released by this procedure and the fibroblasts are actively proliferative in tissue culture. Cultures can be used for cytogenetic analysis after ∼1 week. Slides prepared by this technique can be stained using trypsin-Giemsa banding and analyzed for chromosomal abnormalities in fetal tissue. Chorionic villi may also be assessed by chromosomal microarray analysis (CMA). For this purpose, a method for extraction of high-quality DNA from CVS tissue is also described here. Curr. Protoc. Hum. Genet. 75:8.3.1-8.3.9. © 2012 by John Wiley & Sons, Inc.

11 Reads
  • [Show abstract] [Hide abstract]
    ABSTRACT: Current trends in prenatal genetic testing will affect nursing practice, education, research, and policy making. Although fetal genetic testing has been the traditional focus, new technologies open the possibility of acquiring genomic information for both parents and offspring, revealing windows onto individuals' lifelong health. Noninvasive prenatal testing of cell-free fetal DNA also has become a reality. Some of the recent advances in detecting cytogenetic and heritable molecular variants in pregnancy are overviewed. Exemplars of prenatal tests are presented and related ethical, legal, and social implications are considered. Educating clinicians with updated genomic knowledge has been outpaced by new technologies and direct-to-consumer marketing of prenatal tests. Implications for nursing are discussed.
    Nursing outlook 01/2014; 62(3). DOI:10.1016/j.outlook.2013.12.010 · 1.59 Impact Factor